SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-018526
Filing Date
2023-11-09
Accepted
2023-11-09 15:06:05
Documents
13
Period of Report
2023-11-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20231109x8k.htm   iXBRL 8-K 60636
2 EX-3.1 cydy-20231109xex3d1.htm EX-3.1 10389
  Complete submission text file 0001558370-23-018526.txt   188146

Data Files

Seq Description Document Type Size
3 EX-101.SCH cydy-20231109.xsd EX-101.SCH 3130
4 EX-101.LAB cydy-20231109_lab.xml EX-101.LAB 14761
5 EX-101.PRE cydy-20231109_pre.xml EX-101.PRE 9602
7 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20231109x8k_htm.xml XML 4491
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 231391912
SIC: 2834 Pharmaceutical Preparations